These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Tao S, Yu L, Li J, Xie Z, Huang L, Yang D, Tan Y, Zhang W, Huang X, Xue T. Cardiovasc Diabetol; 2023 Nov 28; 22(1):322. PubMed ID: 38017540 [Abstract] [Full Text] [Related]
3. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention. Chen Q, Xiong S, Zhang Z, Yu X, Chen Y, Ye T, Yang S, Qi L, Chen X, Liu H, Zheng J, Cai L. Cardiovasc Diabetol; 2023 Oct 21; 22(1):284. PubMed ID: 37865753 [Abstract] [Full Text] [Related]
4. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention. Dong S, Zhao Z, Huang X, Ma M, Yang Z, Fan C, Han H, Wang Z, Shi D, Zhou Y. Cardiovasc Diabetol; 2023 Oct 27; 22(1):286. PubMed ID: 37891647 [Abstract] [Full Text] [Related]
5. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y. Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294 [Abstract] [Full Text] [Related]
6. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X. Cardiovasc Diabetol; 2020 Mar 10; 19(1):31. PubMed ID: 32156279 [Abstract] [Full Text] [Related]
7. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Cardiovasc Diabetol; 2020 Jul 23; 19(1):116. PubMed ID: 32703284 [Abstract] [Full Text] [Related]
8. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Xiong S, Chen Q, Chen X, Hou J, Chen Y, Long Y, Yang S, Qi L, Su H, Huang W, Liu H, Zhang Z, Cai L. Cardiovasc Diabetol; 2022 Aug 05; 21(1):145. PubMed ID: 35932019 [Abstract] [Full Text] [Related]
9. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Jiang H, Liu Y, Guo H, Liu Z, Li Z. BMC Cardiovasc Disord; 2024 May 03; 24(1):234. PubMed ID: 38702615 [Abstract] [Full Text] [Related]
10. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Cardiovasc Diabetol; 2023 Mar 30; 22(1):75. PubMed ID: 36997935 [Abstract] [Full Text] [Related]
11. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention. Xiong S, Chen Q, Zhang Z, Chen Y, Hou J, Cui C, Cheng L, Su H, Long Y, Yang S, Qi L, Chen X, Liu H, Cai L. Cardiovasc Diabetol; 2022 Jun 24; 21(1):115. PubMed ID: 35751060 [Abstract] [Full Text] [Related]
12. The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion. Li Y, He S, Wu Z, Li W, Jian W, Cheng Z, Wang C, Shi Y, Liu J. Cardiovasc Diabetol; 2022 Aug 08; 21(1):149. PubMed ID: 35941586 [Abstract] [Full Text] [Related]
13. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. J Atheroscler Thromb; 2021 Nov 01; 28(11):1175-1194. PubMed ID: 33191314 [Abstract] [Full Text] [Related]
14. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents. Zhang Y, Chu C, Zhong Z, Luo YB, Ning FF, Guo N. Front Endocrinol (Lausanne); 2023 Nov 01; 14():1101952. PubMed ID: 36875470 [Abstract] [Full Text] [Related]
15. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome. Wang C, Liao P, Tang C, Chen C, Zhang X. Front Endocrinol (Lausanne); 2024 Nov 01; 15():1423227. PubMed ID: 39257901 [Abstract] [Full Text] [Related]
16. Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study. Wang Y, Wang Y, Sun S, Liu X, Zhao W, Li W, Suo M, Wu Z, Wu X. Lipids Health Dis; 2022 Dec 08; 21(1):134. PubMed ID: 36482415 [Abstract] [Full Text] [Related]
17. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention. Sun T, Huang X, Zhang B, Ma M, Chen Z, Zhao Z, Zhou Y. Front Endocrinol (Lausanne); 2023 Dec 08; 14():1100399. PubMed ID: 36814584 [Abstract] [Full Text] [Related]
18. Triglyceride-Glucose Index as a Predictor of Major Adverse Cardiovascular Events in Post-PCI Patients Diagnosed with In-Stent Restenosis. Wang YF, Kong XH, Tao HM, Tao L. Diabetes Metab Syndr Obes; 2024 Dec 08; 17():2737-2746. PubMed ID: 39072346 [Abstract] [Full Text] [Related]
19. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Cardiovasc Diabetol; 2020 Jul 08; 19(1):108. PubMed ID: 32641127 [Abstract] [Full Text] [Related]
20. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention. Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. Front Endocrinol (Lausanne); 2021 Jul 08; 12():710240. PubMed ID: 34489866 [Abstract] [Full Text] [Related] Page: [Next] [New Search]